Review

February 13, 2023


Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, et al.
Clin Mol Hepatol. 2023;29(3):593-604.

Review

February 15, 2023


Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):605-622.

Review

February 20, 2023


Acute hepatitis C virus infection: clinical update and remaining challenges
Chen-Hua Liu, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):623-642.

Review

March 6, 2023


A decade of liver organoids: Advances in disease modeling
Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, et al.
Clin Mol Hepatol. 2023;29(3):643-669.

Review

March 20, 2023


Acute-on-chronic liver failure: Terminology, mechanisms and management
Vinay Kumar BR, Shiv Kumar Sarin
Clin Mol Hepatol. 2023;29(3):670-689.

Original Article

March 9, 2023


Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, et al.
Clin Mol Hepatol. 2023;29(3):693-704.

Original Article

May 8, 2023


Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
Yu Jun Wong, Vy H. Nguyen, Hwai-I Yang, et al.
Clin Mol Hepatol. 2023;29(3):705-720.

Original Article

March 22, 2023


Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, et al.
Clin Mol Hepatol. 2023;29(3):721-732.

Original Article

May 8, 2023


Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging
Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, et al.
Clin Mol Hepatol. 2023;29(3):733-746.

Original Article

May 10, 2023


Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, et al.
Clin Mol Hepatol. 2023;29(3):747-762.

Original Article

May 30, 2023


Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
Moon Haeng Hur, Yuri Cho, Do Young Kim, et al.
Clin Mol Hepatol. 2023;29(3):763-778.

Original Article

May 15, 2023


Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, et al.
Clin Mol Hepatol. 2023;29(3):779-793.

Original Article

May 17, 2023


Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
Jeayeon Park, Sung Won Chung, Yun Bin Lee, et al.
Clin Mol Hepatol. 2023;29(3):794-809.


Articles in E-pub version are posted online ahead of regular printed publication.

Editorial
Adding to the confusion in more than name
Jacob George
Received September 18, 2023  Accepted September 18, 2023  
View: 51   Download: 3
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Ming-Lun Yeh, Ming-Lung Yu
Received September 15, 2023  Accepted September 18, 2023  
View: 80   Download: 17
Original Article
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study
Vy H. Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen
Received June 14, 2023  Accepted September 7, 2023  
View: 189   Download: 18
Review
Waiting for the changes after the adoption of steatotic liver disease
Eileen L. Yoon, Dae Won Jun
Received August 3, 2023  Accepted September 4, 2023  
View: 200   Download: 43
Editorial
Novel Paradigm in the Treatment of Hepatocellular Carcinoma: Anticipating Breakthroughs with Particle Therapy
Sang Min Yoon
Received August 29, 2023  Accepted August 30, 2023  
View: 160   Download: 11
Correspondence
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Eileen L. Yoon, Dae Won Jun
Received August 15, 2023  Accepted August 25, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0310    [Epub ahead of print]
View: 122   Download: 4
Review Article
Current Evidence and the Potential Role of Proton Beam Therapy for Hepatocellular Carcinoma
Sung Uk Lee, Tae Hyun Kim
Received July 27, 2023  Accepted August 27, 2023  
View: 113   Download: 12
Original Article
Prognostic role of CT analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon
Received June 1, 2023  Accepted August 27, 2023  
View: 161   Download: 11
Review
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
Gi-Ae Kim, Joon Ho Moon, Won Kim
Received July 28, 2023  Accepted August 23, 2023  
View: 411   Download: 93
Letter to the Editor
Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh
Received July 24, 2023  Accepted August 1, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0268    [Epub ahead of print]
View: 197   Download: 9
Editorial
Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
Eugene Han, Yong-ho Lee
Received July 15, 2023  Accepted August 11, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0250    [Epub ahead of print]
View: 263   Download: 29
Letter to the Editor
Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Received July 21, 2023  Accepted August 9, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0261    [Epub ahead of print]
View: 250   Download: 6
Review
Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
Hwa Kyung Byun, Changhwan Kim, Jinsil Seong
Received June 21, 2023  Accepted August 8, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0217    [Epub ahead of print]
View: 343   Download: 25
Snapshot
The role of the hepatic autonomic nervous system
Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin
Received July 10, 2023  Accepted July 24, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0244    [Epub ahead of print]
View: 229   Download: 13
Review
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Received March 26, 2023  Accepted July 18, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0125    [Epub ahead of print]
View: 459   Download: 93
Letter to the Editor
Letter regarding “Evidence-based hyponatremia management in liver disease”
Daphne J. Theodorou, Stavroula J. Theodorou, Ioannis V. Mitselos
Received June 14, 2023  Accepted June 21, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0204    [Epub ahead of print]
View: 319   Download: 15
Original Article
Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim
Received March 29, 2023  Accepted July 4, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0131    [Epub ahead of print]
View: 480   Download: 55
Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe
Received January 30, 2023  Accepted July 5, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0035    [Epub ahead of print]
View: 922   Download: 118
Review
Evidence-based hyponatremia management in liver disease
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Received March 3, 2023  Accepted June 5, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0090    [Epub ahead of print]
View: 637   Download: 107
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
Landon L. Chan, Stephen L. Chan
Received March 22, 2023  Accepted May 25, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0114    [Epub ahead of print]
View: 819   Download: 149  Citation: 1
Hepatorenal syndrome: Current concepts and future perspectives
Chan-Young Jung, Jai Won Chang
Received January 25, 2023  Accepted April 10, 2023  
DOI: https://doi.org/10.3350/cmh.2023.0024    [Epub ahead of print]
View: 2984   Download: 993
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Received November 26, 2022  Accepted March 13, 2023  
DOI: https://doi.org/10.3350/cmh.2022.0420    [Epub ahead of print]
View: 851   Download: 89  Citations: 2
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Received December 2, 2022  Accepted March 7, 2023  
DOI: https://doi.org/10.3350/cmh.2022.0434    [Epub ahead of print]
View: 4153   Download: 195  Citation: 1

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

  • PubMed Central
  • PubMed
  • Scopus
  • KoreaMed
  • KoMCI
  • ScienceCentral
  • DOAJ
  • GoogleScholar
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • Metadata
  • ORCID
  • MeSH on Demand
  • COPE
  • EMBASE
  • KOFST
  • ICMJE
  • Web of SCIENCE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 341
TOTAL : 1453393
Close layer